loading
Precedente Chiudi:
$0.3961
Aprire:
$0.4093
Volume 24 ore:
2.65M
Relative Volume:
0.28
Capitalizzazione di mercato:
$21.40M
Reddito:
-
Utile/perdita netta:
$-11.53M
Rapporto P/E:
-0.0883
EPS:
-4.82
Flusso di cassa netto:
$-11.12M
1 W Prestazione:
-11.84%
1M Prestazione:
+110.68%
6M Prestazione:
+56.31%
1 anno Prestazione:
-65.95%
Intervallo 1D:
Value
$0.403
$0.4333
Intervallo di 1 settimana:
Value
$0.3171
$0.4432
Portata 52W:
Value
$0.15
$1.50

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
Nome
Processa Pharmaceuticals Inc
Name
Telefono
443-776-3133
Name
Indirizzo
601 21ST STREET, SUITE 300, VERO BEACH
Name
Dipendente
13
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
PCSA's Discussions on Twitter

Confronta PCSA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.4251 22.11M 0 -11.53M -11.12M -4.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.39 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
476.55 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.32 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
811.36 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
316.54 35.25B 4.56B -176.77M 225.30M -1.7177

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-25 Iniziato H.C. Wainwright Buy

Processa Pharmaceuticals Inc Borsa (PCSA) Ultime notizie

pulisher
Oct 14, 2025

Can you recover from losses in Processa Pharmaceuticals Inc.July 2025 Intraday Action & Community Trade Idea Sharing - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Should you wait for a breakout in Processa Pharmaceuticals Inc.Trade Volume Summary & Safe Entry Zone Tips - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Top chart patterns to watch in Processa Pharmaceuticals Inc.July 2025 Gainers & Consistent Income Trade Ideas - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Is Processa Pharmaceuticals Inc. stock a buy before product launchesEarnings Recap Summary & AI Driven Stock Price Forecasts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Published on: 2025-10-14 02:28:39 - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Published on: 2025-10-14 00:40:32 - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

What data driven models say about Processa Pharmaceuticals Inc.’s future2025 Earnings Impact & Capital Protection Trading Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

What moving averages say about Processa Pharmaceuticals Inc.2025 Market Outlook & Verified Swing Trading Watchlist - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Applying big data sentiment scoring on Processa Pharmaceuticals Inc.Weekly Gains Summary & Scalable Portfolio Growth Methods - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Processa Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Using economic indicators to assess Processa Pharmaceuticals Inc. potentialPortfolio Gains Summary & Technical Pattern Alert System - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Using AI based signals to follow Processa Pharmaceuticals Inc.Market Weekly Review & Momentum Based Trading Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can swing trading help recover from Processa Pharmaceuticals Inc. lossesJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Live market analysis of Processa Pharmaceuticals Inc.Trade Performance Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Forecasting Processa Pharmaceuticals Inc. price range with options dataWeekly Profit Analysis & Weekly High Momentum Picks - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is Processa Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Spike Watch & Capital Protection Trading Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Processa Pharmaceuticals Inc. stock reacts to inflationary pressures2025 Momentum Check & Free Expert Verified Stock Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight? - Benzinga

Oct 08, 2025
pulisher
Oct 08, 2025

Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq

Oct 08, 2025
pulisher
Oct 07, 2025

TELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates - RTTNews

Oct 07, 2025
pulisher
Oct 06, 2025

Momentum divergence signals in Processa Pharmaceuticals Inc. chart2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 04:03:55 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Can machine learning forecast Processa Pharmaceuticals Inc. recovery2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 04:24:10 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 02:09:35 - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Ulcerated Necrobiosis Lipoidica Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Processa Pharmaceuticals - The Globe and Mail

Sep 30, 2025
pulisher
Sep 30, 2025

Strategies to average down on Processa Pharmaceuticals Inc.Quarterly Trade Review & Daily Growth Stock Investment Tips - newser.com

Sep 30, 2025

Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Processa Pharmaceuticals Inc Azioni (PCSA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Ng George K
Chief Executive Officer
Jan 27 '25
Buy
0.80
87,200
69,542
87,200
Young David
Pres. Research & Development
Jan 27 '25
Buy
0.80
124,500
99,289
205,405
Lin Patrick
Chief Business - Strategy Off
Jan 27 '25
Buy
0.80
43,500
34,691
43,500
$22.52
price up icon 3.86%
$87.14
price up icon 1.30%
$32.33
price down icon 1.77%
$102.92
price up icon 0.39%
$163.71
price up icon 1.49%
biotechnology ONC
$316.00
price down icon 2.19%
Capitalizzazione:     |  Volume (24 ore):